Relief Of The Pain Of Arthritis

Pain Of Fibromyalgia

Pain Relief From Drugs

Ayurvedic Pain
 Relief

Separate Search Page
or search below

Table Of Contents

Rheumatoid Arthritis:

http://clinicaltrials.gov/ct/gui/show/NCT00000401?order=5&JServSessionIdzone_ct=qr8jb52941

Scleroderma:

http://clinicaltrials.gov/ct/gui/show/NCT00005675?order=1&JServSessionIdzone_ct=y4w6gv26i1

The directors of the Center of Excellence for Diseases of Connective Tissues are proud to announce the program for our 2002 International Symposium on Autoimmune Arthritis. The symposium represents a unique opportunity to focus on the immunobiology of autoimmune arthritis with insights provided by internationally recognized researchers in the field. Should you have any questions regarding this symposium, please contact Andrew H Kang. A brochure describing the schedule for the symposium can be found here. Please note that the poster abstract submission deadline of August 1st as listed on the brochure has been extended to September 1st. A PDF version of the registration form for the symposium can be found here.

Pilot and Feasibility Grants

Center of Excellence for Diseases of Connective Tissue

Purpose:

One of the mandates given to each Center of Excellence is to at least quadruple the research funding in the respective areas over the five year period of the Center funding. As a part of our plan to fulfill this mandate, we are again inviting applications for pilot and feasibility research grant from the Center Of Excellence For Diseases Of Connective Tissue. Pilot and feasibility research grants are available for research in the areas of interest to the Center, i.e. autoimmunity, inflammation and tissue repair, fibrotic disorders, and rheumatic diseases. The research project may be basic, clinical or a combination of both. These grants are intended to facilitate the investigators in these areas to generate research data that would enhance the competitiveness of their projects for external funding, such as RO3, RO21, RO1, projects within Program Project grants or SCOR's, or research career development awards from the NIH or nationally peer-reviewed foundations.

Major criteria:

1.              The applicant must be a faculty member in good standing at the UTHSC and currently is, or is interested in becoming, a participating member of the Center Of Excellence For Diseases Of Connective Tissue.

2.              The research project must have high scientific merit.

3.              Potential for successful future peer-reviewed funding must be demonstrated for NIH, other federal or private grants that will accrue indirect cost to the UTHSC.

Funding:

Awards range up to $20,000 for one year depending on the needs. The NIH offers pilot study grants such as R21 and RO3 that require only minimal to modest amount of preliminary data. It is hoped that the recipients of the P & F grants should be able to apply for at least these types of grants after 1 year of support.

Application procedure:

1.              Each application will be peer-reviewed.

2.              The application should contain the following elements and should ordinarily not exceed five type-written pages (single-spaced) in length.

An editable, PDF version of the application package can be obtained here. 

i.               Title of the project, name and academic title of the PI

ii.              Introduction and specific aims

iii.            Background and rationale

iv.             Preliminary data if any

v.              Methods of procedure

vi.             Plans for future external funding from NIH, other federal or private sources.

3.              Budget page

4.              CV of the PI (3 page NIH style or its equivalent) with a list of "other support".

Review Criteria:

The following criteria will be assessed in arriving at a priority score for the proposed P&F grants.

i.               Degree of innovation of the proposal

ii.              Significance of the proposed research and relevance to diseases of connective tissue

iii.            Soundness of the experimental plan

iv.             Investigator potential to obtain funding from government and private foundations that pay indirect costs to the University of Tennessee Health Science Center. For investigators previously funded by a Center of Excellence in Diseases of Connective Tissue P&F grant, whether that P&F grant resulted in submissions or funding of larger grants that return indirect costs to the University of Tennessee Health Science Center.

v.              Research environment

vi.             Human subject use (IRB approval)

vii.           Animal subject use (IACUC approval)

Deadline:

Submit 9 copies of the application to Dr. Andrew Kang, Coleman Building Rm. G326, 956 Court Avenue, Memphis, TN 38163 before April 18, 2003. Alternatively, you may submit your application by email to jbaker@utmem.edu. Funding decision will be made within 1 month after the deadline.

I promise to answer your message -- click here to send me a personal message

Dear Karl,